For research use only. Not for therapeutic Use.
hPL-IN-2(CAT: I040688) is a potent and selective inhibitor targeting human placental lactogen (hPL), a hormone involved in metabolic regulation during pregnancy. By modulating hPL activity, hPL-IN-2 offers a promising tool for investigating the role of placental hormones in glucose and lipid metabolism, fetal growth, and gestational diabetes. This small molecule inhibitor is useful in both in vitro and in vivo studies to explore endocrine signaling pathways and hormone-receptor interactions.
| CAS Number | 24900-61-6 |
| Synonyms | 3,5-dichloro-N-[3-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxybenzamide |
| Molecular Formula | C19H11Cl4NO3 |
| Purity | ≥95% |
| IUPAC Name | 3,5-dichloro-N-[3-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxybenzamide |
| InChI | InChI=1S/C19H11Cl4NO3/c20-10-1-4-13(5-2-10)27-17-6-3-12(9-15(17)22)24-19(26)14-7-11(21)8-16(23)18(14)25/h1-9,25H,(H,24,26) |
| InChIKey | HPIKHGXRCDJEKT-UHFFFAOYSA-N |
| SMILES | C1=CC(=CC=C1OC2=C(C=C(C=C2)NC(=O)C3=C(C(=CC(=C3)Cl)Cl)O)Cl)Cl |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
